Institutional investors purchased a net $2.9 million shares of ICPT during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 76.72% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRONTIER CAPITAL MANAGEMENT CO. ... Bought 18.3 Thousand shares of Intercept Pharmaceuticals...
CANDRIAM BELGIUM SA Bought 6.0 Thousand shares of Intercept Pharmaceuticals...